150 related articles for article (PubMed ID: 19944186)
1. Metabolomic strategies to study lipotoxicity in cardiovascular disease.
Waterman CL; Kian-Kai C; Griffin JL
Biochim Biophys Acta; 2010 Mar; 1801(3):230-4. PubMed ID: 19944186
[TBL] [Abstract][Full Text] [Related]
2. New insights into cardiovascular and lipid metabolomics.
Giovane A; Balestrieri A; Napoli C
J Cell Biochem; 2008 Oct; 105(3):648-54. PubMed ID: 18729082
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease.
Ussher JR; Elmariah S; Gerszten RE; Dyck JR
J Am Coll Cardiol; 2016 Dec; 68(25):2850-2870. PubMed ID: 28007146
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics in cardiovascular diseases.
Kordalewska M; Markuszewski MJ
J Pharm Biomed Anal; 2015 Sep; 113():121-36. PubMed ID: 25958299
[TBL] [Abstract][Full Text] [Related]
5. Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease.
Shah SH; Newgard CB
Circ Cardiovasc Genet; 2015 Apr; 8(2):410-9. PubMed ID: 25901039
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics and ischaemic heart disease.
Rasmiena AA; Ng TW; Meikle PJ
Clin Sci (Lond); 2013 Mar; 124(5):289-306. PubMed ID: 23157406
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review.
Ruiz-Canela M; Hruby A; Clish CB; Liang L; Martínez-González MA; Hu FB
J Am Heart Assoc; 2017 Sep; 6(10):. PubMed ID: 28963102
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics signature improves the prediction of cardiovascular events in elderly subjects.
Rizza S; Copetti M; Rossi C; Cianfarani MA; Zucchelli M; Luzi A; Pecchioli C; Porzio O; Di Cola G; Urbani A; Pellegrini F; Federici M
Atherosclerosis; 2014 Feb; 232(2):260-4. PubMed ID: 24468136
[TBL] [Abstract][Full Text] [Related]
9. Understanding different facets of cardiovascular diseases based on model systems to human studies: a proteomic and metabolomic perspective.
Basak T; Varshney S; Akhtar S; Sengupta S
J Proteomics; 2015 Sep; 127(Pt A):50-60. PubMed ID: 25956427
[TBL] [Abstract][Full Text] [Related]
10. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.
Zhao YY; Cheng XL; Lin RC
Int Rev Cell Mol Biol; 2014; 313():1-26. PubMed ID: 25376488
[TBL] [Abstract][Full Text] [Related]
11. Understanding mouse models of disease through metabolomics.
Griffin JL
Curr Opin Chem Biol; 2006 Aug; 10(4):309-15. PubMed ID: 16815732
[TBL] [Abstract][Full Text] [Related]
12. A practical guide to metabolomic profiling as a discovery tool for human heart disease.
Heather LC; Wang X; West JA; Griffin JL
J Mol Cell Cardiol; 2013 Feb; 55():2-11. PubMed ID: 23231771
[TBL] [Abstract][Full Text] [Related]
13. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
14. Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
Cheng S; Shah SH; Corwin EJ; Fiehn O; Fitzgerald RL; Gerszten RE; Illig T; Rhee EP; Srinivas PR; Wang TJ; Jain M;
Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28360086
[TBL] [Abstract][Full Text] [Related]
15. Chronic Diseases and Lifestyle Biomarkers Identification by Metabolomics.
Mastrangelo A; Barbas C
Adv Exp Med Biol; 2017; 965():235-263. PubMed ID: 28132183
[TBL] [Abstract][Full Text] [Related]
16. Power of metabolomics in biomarker discovery and mining mechanisms of obesity.
Zhang A; Sun H; Wang X
Obes Rev; 2013 Apr; 14(4):344-9. PubMed ID: 23279162
[TBL] [Abstract][Full Text] [Related]
17. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
18. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease.
Shah SH; Sun JL; Stevens RD; Bain JR; Muehlbauer MJ; Pieper KS; Haynes C; Hauser ER; Kraus WE; Granger CB; Newgard CB; Califf RM; Newby LK
Am Heart J; 2012 May; 163(5):844-850.e1. PubMed ID: 22607863
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics: a new era in cardiology?
Mercuro G; Bassareo PP; Deidda M; Cadeddu C; Barberini L; Atzori L
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):800-5. PubMed ID: 21934525
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
